These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 10955236

  • 1. [Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
    Yamaguchi K, Miyazaki S, Kashitani F, Iwata M, Kanda M, Tsujio Y, Okada J, Tazawa Y, Watanabe N, Uehara N, Igari J, Oguri T, Kaimori M, Kawamura C, Iinuma Y, Nisawataira T, Tashiro H, Ueno K, Ishigo S, Yasujima M, Kawahara S, Itoh C, Yoshida T, Yamanaka K, Toyoshima S, Katoh J, Kudoh M, Matsushima T, Niki Y, Miyashita N, Funato T, Kaku M, Sato N, Saito Y, Ishii K, Kuwabara M, Hongo T, Negayama K, Kamihira S, Miyazaki Y, Takii M, Ishii M, Nakagawa K, Ono J, Takada T, Murakami N, Taira M, Tamaki I, Matsudou Y, Nakasone I.
    Jpn J Antibiot; 2000 Jun; 53(6):387-408. PubMed ID: 10955236
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study.
    Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA, Gemifloxacin Surveillance Study Research Group.
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):814-9. PubMed ID: 11783700
    [Abstract] [Full Text] [Related]

  • 4. [In vitro activities of 23 antimicrobial agents against 4,993 gram-positive and gram-negative bacterial strains isolated from multicenter of Japan during 1994--in vitro susceptibility surveillance.Levofloxacin-Surveillance Group].
    Yamaguchi K, Ohno A, Kashitani F, Iwata M, Shimizu Y, Sato S, Matsumoto I, Itoh M, Funato T, Tsujio Y, Nagasawa M, Tachibana M, Kanno H, Matsuda K, Okada J, Takaya H, Nakamura T, Igari J, Sugimoto K, Oguri T, Toyoshima S, Okada M, Nakai T, Kuwabara M, Nagasawa Z.
    Jpn J Antibiot; 1999 Feb; 52(2):75-92. PubMed ID: 10221176
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J.
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.
    Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA, Gemifloxacin Surveillance Study Research Group.
    Diagn Microbiol Infect Dis; 2001 Sep; 40(1-2):51-7. PubMed ID: 11448564
    [Abstract] [Full Text] [Related]

  • 7. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
    Matsuzaki K, Watabe E, Yoshimori K, Shikano M, Sato Y, Hasegawa M, Kobayashi I.
    Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734
    [Abstract] [Full Text] [Related]

  • 8. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ, Meyer JM, Chuck SK, Jung R, Messick CR, Pendland SL.
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [Abstract] [Full Text] [Related]

  • 9. [Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections].
    Kobayashi I, Matsuzaki K, Omika K, Hasegawa M, Sato Y.
    Jpn J Antibiot; 2007 Apr; 60(2):98-106. PubMed ID: 17612257
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
    Madhusudhan KT, Counts C, Lody C, Carter O, Dodson S, Ojha N.
    Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN, Pfaller MA.
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
    Pontani D, Washton H, Bouchillon S, Johnson J.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):413-9. PubMed ID: 9758284
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates.
    Gönüllü N, Aktaş Z, Salcioglu M, Bal C, Ang O.
    Clin Microbiol Infect; 2001 Sep; 7(9):499-503. PubMed ID: 11678934
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV, Ho DH, LeBlanc B, Streeter H, Dvorak T.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [Abstract] [Full Text] [Related]

  • 16. [In vitro susceptibilites to levofloxacin and various antibacterial agents of 11,475 clinical isolates obtained from 52 centers in 2002].
    Yamaguchi K, Ohno A, Kashitani F, Iwata M, Kanda M, Tsujio Y, Shimoyama N, Okujima H, Ito M, Kawaguchi H, Chiba H, Akizawa K, Katayama Y, Sugimoto K, Tashiro H, Kaimori M, Suwabe A, Obata R, Sugiyama T, Toyoshima S, Kato J, Kaku M, Kanemitsu K, Kunishima H, Okada J, Tazawa Y, Igari J, Oguri T, Watanabe K, Kobayashi Y, Uchida H, Totsuka K, Kon S, Nakamura K, Matsuda K, Hayashi I, Shiotani J, Shiotani J, Kanno H, Itoh A, Sumitomo M, Uchida T, Kawabata A, Oiwa C, Iwata M, Horii T, Ishigo S, Yoshimura T, Ichiyama S, Wada Y, Kimura S, Maesaki S, Itoh K, Noda Y, Yamashita T, Yamaguchi I, Kageyama F, Shaku E, Baba H, Inuzuka K, Okabe H, Tatewaki K, Moro K, Aihara M, Matsushima T, Niki Y, Kuw Abara M, Ikawa S, Tanaka M, Hinoda Y, Sugiura T, Kamioka M, Ono J, Takata T, Makino H, Murase M, Miyamoto H, Aizawa H, Honda J, Takii M, Nagasawa Z, Aoki Y, Hamazaki N, Tsutsui T, Nakagawa K, Iwata M, Hiramatsu K, Saikawa T, Yamane N, Kimoto H, Kotani T, Kageoka T, Hongo T, Masuda J, Miyanohara H, Tsujimura M, Yasujima M, Hayashi I.
    Jpn J Antibiot; 2005 Feb; 58(1):17-44. PubMed ID: 15849869
    [Abstract] [Full Text] [Related]

  • 17. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
    Yamaguchi K, Ohno A, Kashitani F, Iwata M, Kanda M, Tsujio Y, Sugiyama T, Toyoshima S, Kato J, Watanabe N, Kaku M, Kanemitsu K, Kunishima H, Kawaguchi H, Okada J, Shimoyama N, Igari J, Oguri T, Kaimori M, Watanabe K, Kobayashi Y, Uchida H, Katayama Y, Sugimoto K, Tashiro H, Kanno H, Yasujima M, Itoh K, Suwabe A, Obata R, Okada M, Kobayashi S, Tsuzimura M, Itoh A, Sumitomo M, Taminato T, Negayama K, Baba H, Makino H, Murase M, Miyamoto H, Minakuchi K, Ishigo S, Takii M, Horii T, Ono J, Takata T, Yamanaka K, Hamazaki N, Tsutsui T, Okabe H, Tatewaki K, Moro K, Hiramatsu K, Saikawa T, Ichiyama S, Nagasawa Z, Aoki Y, Matsushima T, Niki Y, Hirakata Y, Kohno S, Kuwabara M, Nakagawa K, Kageoka T, Hongo T, Yamane N.
    Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina.
    Lopez H, Stepanik D, Vilches V, Scarano S, Sarachian B, Mikaelian G, Finlay J, Sucari A.
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):187-92. PubMed ID: 11576792
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activity of trovafloxacin, of other fluoroquinolones and of related antimicrobials against clinical isolates. Grupo colaborativo WHONET-Argentina].
    Rossi A, Galas M, Tokumoto M, Guelfand L, Lopardo H.
    Medicina (B Aires); 1999 Aug; 59 Suppl 1():8-16. PubMed ID: 10436549
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the activity of ciprofloxacin and levofloxacin with other agents against respiratory tract pathogens.
    Wise R, Andrews JM.
    J Chemother; 1998 Aug; 10(4):276-9. PubMed ID: 9720464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.